NUFIP1 and colorectal carcinoma: In the current study, we combined microarrays, online database searches, cDNA array-based quantitative PCR (qPCR) and tissue microarray (TMA)-based immunohistochemistry (IHC) to analyze the expression of NUFIP1 in CRC samples and to correlate its expression with disease progression and prognosis.